David Grainger

About David Grainger

Birth Day: October 12, 1966
Alma mater: Cambridge University
Occupation: venture capitalist, medicxi, biotechnology executive, Methuselah Health Ltd., blogger

David Grainger

David Grainger was born on October 12, 1966. Entrepreneur David Grainger (III) along with wife Janice Stone started The Guild of Automotive Restorers in 1991. Also Known as Restoration Garage, now in its fourth season. The Guild has been featured on TV, radio and in print all over the world. David Grainger enjoys flying planes, riding horses and racing boats. Maybe this is why , "The Guild was established to give David the opportunity and resources needed for such costly hobbies and endeavors. In his previous life before The Guild Davis could be found at Zoos and Sanctuaries helping injured birds, training large cats, interacting with reptiles inclusive of poisonous snakes like the King Cobra. He is also an accomplished professional diver with a history of working with sharks. He had been a professional wildlife artist with published works in the Globe and Mail ,National Post and Octane magazine. David has lead an eclectic life and even at age 64 shows little to no signs of slowing down.

Does David Grainger Dead or Alive?

As per our current Database, David Grainger is still alive (as per Wikipedia, Last update: May 10, 2020).

🎂 David Grainger - Age, Bio, Faces and Birthday

Currently, David Grainger is 55 years, 7 months and 15 days old. David Grainger will celebrate 56rd birthday on a Wednesday 12th of October 2022. Below we countdown to David Grainger upcoming birthday.

Days
Hours
Minutes
Seconds
Popular As David Grainger
Occupation
Age 54 years old
Zodiac Sign
Born October 12, 1966 ()
Birthday October 12
Town/City
Nationality

🌙 Chinese Zodiac Signs

David Grainger was born in the Year of the Horse. Those born under the Chinese Zodiac sign of the Horse love to roam free. They’re energetic, self-reliant, money-wise, and they enjoy traveling, love and intimacy. They’re great at seducing, sharp-witted, impatient and sometimes seen as a drifter. Compatible with Dog or Tiger.

Some David Grainger images

Biography/Timeline

1989

Reared in England, Grainger graduated with degree in Natural Sciences (Biochemistry) from Cambridge University in 1989, and a PhD in Vascular Cell Biology from the same institution in 1992.

1997

After receiving his PhD, Grainger undertook post-doctoral research in the British Heart Foundation Smooth Muscle Cell laboratory at Cambridge University. Following publications in Nature and elsewhere setting out his Protective Cytokine Hypothesis explaining the role of the cytokine TGF-beta 1 in the cardiovascular system, Grainger was appointed principal investigator in the Department of Medicine at his alma mater, Cambridge University, in 1997.

2001

While at Cambridge University, Grainger founded life sciences companies including FingerPrint Diagnostics (2001), and Funxional Therapeutics (2005). FingerPrint Diagnostics merged with SmartBead Technologies to form Pronostics, a molecular diagnostics company, in 2006. Funxional Therapeutics, based on an anti-inflammatory drug candidate spun-out from Grainger's Cambridge University lab, became an Index Ventures portfolio company where Grainger also served as chief scientific officer until it was sold to Boehringer Ingelheim in 2012.

2012

Grainger joined Index Ventures in 2012, and a Blogger on topics related to the pharmaceutical industry under the pen name “DrugBaron”. where he was involved with funding and advising a variety of companies, including XO1, a biotech company developing an anticoagulant, where he served as chairman and interim CEO before it was sold to Johnson & Johnson He co-founded medicxi in February 2016 with fellow former Index Ventures partners Francesco De Rubertis, Kevin Johnson and Michele Ollier.

2019

He was formerly with Index Ventures, an international venture capital firm with offices in London, Geneva and San Francisco, in the firm’s life sciences practice. He also writes for Forbes.com on topics related to the pharmaceutical industry.

David Grainger trend